Skip to main content

Lavaca Capital LLC

SEC CIK
0001641447
Latest filing
Aug 14, 2026

ABBV holding history

AbbVie Inc. in every 13F filed by Lavaca Capital LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ABBV overviewAll 13F holders of ABBVFull Q2 2026 holdings

Shares (Q2 2026)
2,819
Value
$709.4K
% of portfolio
0.1%
Quarters held
22
Since Q1 2021
Holdings of ABBV by Lavaca Capital LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20262,819$709.4K0.1%+650+30.0%AddedHolders
Q1 20262,169$471.7K0.1%+384+21.5%AddedHolders
Q4 20251,785$407.9K0.1%00.0%UnchangedHolders
Q3 20251,785$413.3K0.1%−2,210−55.3%ReducedHolders
Q2 20253,995$741.6K0.3%+219+5.8%AddedHolders
Q1 20253,776$791.1K0.4%−248−6.2%ReducedHolders
Q4 20244,024$715.1K0.3%+286+7.7%AddedHolders
Q3 20243,738$738.2K0.4%−3,883−51.0%ReducedHolders
Q2 20247,621$1.31M0.7%+20+0.3%AddedHolders
Q1 20247,601$1.38M0.8%+1,396+22.5%AddedHolders
Q4 20236,205$961.6K0.6%−2,922−32.0%ReducedHolders
Q3 20239,127$1.36M0.5%−1,772−16.3%ReducedHolders
Q2 202310,899$1.47M0.5%−8,437−43.6%ReducedHolders
Q1 202319,336$2.94M0.7%−1,277−6.2%ReducedHolders
Q4 202220,613$3.12M1.2%−181−0.9%ReducedHolders
Q3 202220,794$2.92M1.6%−5,227−20.1%ReducedHolders
Q2 202226,021$3.89M2.0%+247+1.0%AddedHolders
Q1 202225,774$4.18M1.8%−31,609−55.1%ReducedHolders
Q4 202157,383$7.77M3.4%−8,079−12.3%ReducedHolders
Q3 202165,462$7.06M3.5%−10,387−13.7%ReducedHolders
Q2 202175,849$8.54M4.4%+6,610+9.5%AddedHolders
Q1 202169,239$7.49M4.3%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.